Elam Nevan C 4
4 · Savara Inc · Filed Dec 29, 2023
Insider Transaction Report
Form 4
Savara IncSVRA
Elam Nevan C
Director
Transactions
- Exercise/Conversion
Common Stock
2023-12-28$1.23/sh+40,000$49,200→ 116,343 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-28−1,758→ 0 totalExercise: $0.82Exp: 2024-07-24→ Common Stock (1,758 underlying) - Exercise/Conversion
Common Stock
2023-12-28$0.82/sh+1,758$1,442→ 64,343 total - Exercise/Conversion
Common Stock
2023-12-28$1.59/sh+12,000$19,080→ 76,343 total - Sale
Common Stock
2023-12-28$4.71/sh−93,843$442,291→ 22,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-28−12,000→ 0 totalExercise: $1.59Exp: 2029-12-20→ Common Stock (12,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-28−40,000→ 0 totalExercise: $1.23Exp: 2030-12-16→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.
- [F3]The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019.
- [F4]The shares subject to the option vested and became exercisable on December 16, 2021.